Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 2

Biologics: Targets and Therapy


Archive: Volume 2, 2008


Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses

Yong-Hong Yi, Wen-Chao Guo, Wei-Wen Sun, Tao Su, Han Lin, et al

Biologics: Targets and Therapy 2008, 2:339-344

Published Date: 6 June 2008

Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition

Bostjan Humar, Les McNoe, Anita Dunbier, Rosemary Heathcott, Antony W Braithwaite, Anthony E Reeve

Biologics: Targets and Therapy 2008, 2:329-337

Published Date: 6 June 2008

Cognitive performance and the thymus among HIV-infected subjects receiving HAART

Maria J Miguez-Burbano, John E Lewis, Jose Moreno, Joel Fishman

Biologics: Targets and Therapy 2008, 2:321-327

Published Date: 6 June 2008

Review of the use of idursulfase in the treatment of mucopolysaccharidosis II

T Andrew Burrow, Nancy D Leslie

Biologics: Targets and Therapy 2008, 2:311-320

Published Date: 6 June 2008

Mycophenolate mofetil in the treatment of lupus nephritis

Patrick FK Yong, David P D’Cruz

Biologics: Targets and Therapy 2008, 2:297-310

Published Date: 6 June 2008

Natalizumab in the treatment of Crohn’s disease

Danila Guagnozzi, Renzo Caprilli

Biologics: Targets and Therapy 2008, 2:275-284

Published Date: 6 June 2008

Selenium and thyroid autoimmunity

Roberto Negro

Biologics: Targets and Therapy 2008, 2:265-273

Published Date: 6 June 2008

Strategies for regenerating injured axons after spinal cord injury – insights from brain development

Masaki Ueno, Toshihide Yamashita

Biologics: Targets and Therapy 2008, 2:253-264

Published Date: 6 June 2008

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

Jennifer S Carew, Steffan T Nawrocki, Francis J Giles, John L Cleveland

Biologics: Targets and Therapy 2008, 2:201-204

Published Date: 6 June 2008

Natalizumab for the treatment of relapsing multiple sclerosis

Richard A Rudick, Michael A Panzara

Biologics: Targets and Therapy 2008, 2:189-199

Published Date: 6 June 2008

The role of basiliximab in the evolving renal transplantation immunosuppression protocol

Paola Salis, Chiara Caccamo, Roberto Verzaro, Salvatore Gruttadauria, Mary Artero

Biologics: Targets and Therapy 2008, 2:175-188

Published Date: 6 June 2008